HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Claim Ruling Rejects FTC View Of “Competent And Reliable” Evidence

This article was originally published in The Tan Sheet

Executive Summary

In a decision that suggests FTC may have to broaden what it considers competent and reliable evidence, a federal court in Florida rules supplement firm Garden of Life performed adequate due diligence in making claims and was not in contempt of an order for permanent injunction.

You may also be interested in...



Fair Standard Remains For Supplement, Drug Claim Substantiation – FTC

The Federal Trade Commission says consent orders that require more clinical tests to substantiate health claims than are required for other product categories are fair because they are based on the nature of the claims, agency officials say.

Garden Of Life Faces $20M Penalty For Alleged Violation Of FTC 2006 Order

The Federal Trade Commission seeks more than $20 million from Garden of Life to cover consumer redress, alleging the supplement firm made claims in violation of a 2006 order for permanent injunction.

FTC's Consent Orders Chill Speech In Industry, Emord Petition Says

The Federal Trade Commission's recently adopted requirements for substantiating health claims for dietary supplements have a chilling effect on free speech and violate statutory and constitutional regulations, a petition to the agency says.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124757

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel